Quansys Biosciences Q-Plex Human Environmental Enteric Dysfunction (11-Plex)

An estimated 25% of the world’s children under five have stunted growth resulting from environmental enteric dysfunction (EED), a condition also associated with cognitive development deficits and reduced responsiveness to oral vaccines. Although the causes of stunting are multifactorial, recent findings implicate the central role of EED, a subclinical disorder caused by repeated exposure to enteric pathogens found in food, water and sanitation systems.

To accelerate the development of interventions addressing EED, Quansys Biosciences developed the Q-Plex Human Environmental Enteric Dysfunction (11-Plex) — a robust and effective laboratory-based tool for screening individuals and populations at risk of developing or currently suffering from EED in clinical research.

The multiplex test simultaneously measures up to 11 biomarkers in a single sample of human serum, generating a profile of an individual’s nutritional and inflammatory biomarkers as well as growth hormones and intestinal damage. Compared to a single sample, the multiplexing technology enables researchers to obtain much more information in less time, the company claims. The technology is also easy to use, so samples can be analysed near the communities in which they are collected.